Northsea Therapeutics
6 known investors
Find your way into Northsea Therapeutics
NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH. Its programs target patient populations with limited existing treatment options.
Investors · 6
Frequently asked questions
- What does Northsea Therapeutics do?
- NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH. Its programs target patient populations with limited existing treatment options.
- Who are Northsea Therapeutics's investors?
- Northsea Therapeutics's investors include New Science Ventures, venBio Partners, Ysios Capital, BGV, Novo Holdings, Sofinnova Ventures.